{"transactions":[{"id":3630389,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":6174,"price":62.6066,"value":386533.1484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $62.50 to $62.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":328436,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":3630388,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":6814,"price":62.1082,"value":423205.2748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $61.435 to $62.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":334610,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":3630387,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-08T23:00:27.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":7012,"price":60.6579,"value":425333.1948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $60.435 to $61.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":341424,"source":{"system":"sec-edgar","filing":"0001610717-26-000405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071726000405/form4.xml","form_type":"4"}},{"id":687814,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T16:11:23.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":58.725,"value":176175.0,"ownership":{"direct":true},"balance_after":348436,"source":{"system":"sec-edgar","filing":"0001610717-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000358/form4.xml","form_type":"4"}},{"id":687813,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T16:11:23.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":17000,"price":57.5812,"value":978880.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $57.50 to $58.1525. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":351436,"source":{"system":"sec-edgar","filing":"0001610717-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000358/form4.xml","form_type":"4"}},{"id":745964,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T19:26:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":368436,"source":{"system":"sec-edgar","filing":"0001610717-26-000194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071726000194/form4.xml","form_type":"4"}},{"id":1121072,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T17:22:22.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":359607,"source":{"system":"sec-edgar","filing":"0001610717-25-000170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071725000170/form4.xml","form_type":"4"}},{"id":1480370,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-06-13T16:26:22.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":8649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":344250,"source":{"system":"sec-edgar","filing":"0001610717-24-000330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071724000330/form4.xml","form_type":"4"}},{"id":1851761,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T17:42:42.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4661,"derivative":{"exercise_price":57.62,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":4661},"source":{"system":"sec-edgar","filing":"0001610717-23-000175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071723000175/form4.xml","form_type":"4"}},{"id":1851760,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-16T17:42:42.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":335601,"source":{"system":"sec-edgar","filing":"0001610717-23-000175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071723000175/form4.xml","form_type":"4"}},{"id":1863647,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-07T18:32:02.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":54.8894,"value":548894.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $54.47 to $55.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":333736,"source":{"system":"sec-edgar","filing":"0001610717-23-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000161071723000099/form4.xml","form_type":"4"}},{"id":2227261,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T17:18:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5300,"derivative":{"exercise_price":39.62,"expiration_date":"2032-06-15","underlying":"Class A Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001567619-22-013121","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761922013121/doc1.xml","form_type":"4"}},{"id":2227260,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T17:18:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person\ncontinuing as a service provider through each such date."}],"balance_after":343736,"source":{"system":"sec-edgar","filing":"0001567619-22-013121","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761922013121/doc1.xml","form_type":"4"}},{"id":2448056,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-04T18:13:45.000Z","date":"2021-12-30","kind":"sale","acquired":false,"shares":1782,"price":151.565,"value":270088.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $151.02 to $151.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":341616,"source":{"system":"sec-edgar","filing":"0001567619-22-000366","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761922000366/doc1.xml","form_type":"4"}},{"id":2448055,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-04T18:13:45.000Z","date":"2021-12-30","kind":"sale","acquired":false,"shares":3218,"price":150.5596,"value":484500.7928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":343398,"source":{"system":"sec-edgar","filing":"0001567619-22-000366","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761922000366/doc1.xml","form_type":"4"}},{"id":2485326,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-03T17:51:29.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":100,"price":155.55,"value":15555.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":346616,"source":{"system":"sec-edgar","filing":"0001567619-21-021614","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921021614/doc1.xml","form_type":"4"}},{"id":2485325,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-03T17:51:29.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":100,"price":154.02,"value":15402.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":346716,"source":{"system":"sec-edgar","filing":"0001567619-21-021614","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921021614/doc1.xml","form_type":"4"}},{"id":2485324,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-03T17:51:29.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1100,"price":151.7932,"value":166972.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $151.53 to $152.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":346816,"source":{"system":"sec-edgar","filing":"0001567619-21-021614","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921021614/doc1.xml","form_type":"4"}},{"id":2485323,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-03T17:51:29.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1700,"price":151.0993,"value":256868.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $151.00 to $151.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":347916,"source":{"system":"sec-edgar","filing":"0001567619-21-021614","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921021614/doc1.xml","form_type":"4"}},{"id":2485322,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-03T17:51:29.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2000,"price":150.5108,"value":301021.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $150.00 to $150.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":349616,"source":{"system":"sec-edgar","filing":"0001567619-21-021614","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921021614/doc1.xml","form_type":"4"}},{"id":2504541,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-18T19:47:48.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":100,"price":160.32,"value":16032.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":351616,"source":{"system":"sec-edgar","filing":"0001567619-21-020783","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921020783/doc1.xml","form_type":"4"}},{"id":2504540,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-18T19:47:48.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":1048,"price":159.8019,"value":167472.3912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $159.23 to $160.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":351716,"source":{"system":"sec-edgar","filing":"0001567619-21-020783","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921020783/doc1.xml","form_type":"4"}},{"id":2504539,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-18T19:47:48.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":3052,"price":158.7888,"value":484623.4176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $158.19 to $159.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":352764,"source":{"system":"sec-edgar","filing":"0001567619-21-020783","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921020783/doc1.xml","form_type":"4"}},{"id":2504538,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-18T19:47:48.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":800,"price":157.5481,"value":126038.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $157.02 to $157.845. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":355816,"source":{"system":"sec-edgar","filing":"0001567619-21-020783","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921020783/doc1.xml","form_type":"4"}},{"id":2525887,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":300,"price":164.58,"value":49374.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $164.55 to $164.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":356616,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2525886,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2906,"price":163.8899,"value":476264.0494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $163.50 to $164.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":356916,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2525885,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":1494,"price":163.0985,"value":243669.159,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $162.50 to $163.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":359822,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2525884,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":100,"price":161.52,"value":16152.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":361316,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2525883,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":100,"price":160.75,"value":16075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":361416,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2525882,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-11-03T19:13:14.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":100,"price":160.33,"value":16033.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":361516,"source":{"system":"sec-edgar","filing":"0001567619-21-019298","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921019298/doc1.xml","form_type":"4"}},{"id":2538056,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-20T17:39:29.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":300,"price":152.1968,"value":45659.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $151.79 to $152.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":361616,"source":{"system":"sec-edgar","filing":"0001567619-21-018503","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921018503/doc1.xml","form_type":"4"}},{"id":2538055,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-20T17:39:29.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":300,"price":151.4133,"value":45423.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $151.03 to $151.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":361916,"source":{"system":"sec-edgar","filing":"0001567619-21-018503","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921018503/doc1.xml","form_type":"4"}},{"id":2538054,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-20T17:39:29.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":4400,"price":150.5136,"value":662259.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $150.00 to $150.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":362216,"source":{"system":"sec-edgar","filing":"0001567619-21-018503","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921018503/doc1.xml","form_type":"4"}},{"id":2544319,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-12T16:15:51.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":5000,"price":150.1798,"value":750899.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $150.00 to $150.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":366616,"source":{"system":"sec-edgar","filing":"0001567619-21-018209","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000156761921018209/doc1.xml","form_type":"4"}},{"id":2563883,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-20T19:26:53.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":1169,"price":157.7455,"value":184404.4895,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $157.26 to $158.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":371616,"source":{"system":"sec-edgar","filing":"0001209191-21-056956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121056956/doc4.xml","form_type":"4"}},{"id":2563882,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-20T19:26:53.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":1631,"price":156.7217,"value":255613.0927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $156.25 to $157.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":372785,"source":{"system":"sec-edgar","filing":"0001209191-21-056956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121056956/doc4.xml","form_type":"4"}},{"id":2563881,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-20T19:26:53.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":1500,"price":155.689,"value":233533.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $155.19 to $156.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":374416,"source":{"system":"sec-edgar","filing":"0001209191-21-056956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121056956/doc4.xml","form_type":"4"}},{"id":2563880,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-20T19:26:53.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":700,"price":154.4529,"value":108117.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $154.085 to $154.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":375916,"source":{"system":"sec-edgar","filing":"0001209191-21-056956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121056956/doc4.xml","form_type":"4"}},{"id":2578841,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-03T19:55:07.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":296,"price":179.1538,"value":53029.5248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $179.12 to $179.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":376616,"source":{"system":"sec-edgar","filing":"0001209191-21-054901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121054901/doc4.xml","form_type":"4"}},{"id":2578840,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-03T19:55:07.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1104,"price":178.3368,"value":196883.8272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $178.06 to $178.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":376912,"source":{"system":"sec-edgar","filing":"0001209191-21-054901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121054901/doc4.xml","form_type":"4"}},{"id":2578839,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-03T19:55:07.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":2300,"price":177.6237,"value":408534.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $177.06 to $178.035. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":378016,"source":{"system":"sec-edgar","filing":"0001209191-21-054901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121054901/doc4.xml","form_type":"4"}},{"id":2578838,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-03T19:55:07.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1000,"price":176.356,"value":176356.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $175.93 to $176.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":380316,"source":{"system":"sec-edgar","filing":"0001209191-21-054901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121054901/doc4.xml","form_type":"4"}},{"id":2578837,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-03T19:55:07.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":300,"price":175.3583,"value":52607.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $174.87 to $175.615. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":381316,"source":{"system":"sec-edgar","filing":"0001209191-21-054901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121054901/doc4.xml","form_type":"4"}},{"id":2597514,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-18T18:56:04.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":600,"price":160.5633,"value":96337.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $160.45 to $161.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":381616,"source":{"system":"sec-edgar","filing":"0001209191-21-052383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121052383/doc4.xml","form_type":"4"}},{"id":2597513,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-18T18:56:04.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":2790,"price":159.9341,"value":446216.139,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $159.40 to $160.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":382216,"source":{"system":"sec-edgar","filing":"0001209191-21-052383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121052383/doc4.xml","form_type":"4"}},{"id":2597512,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-18T18:56:04.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":1310,"price":158.8369,"value":208076.339,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $158.395 to $159.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":385006,"source":{"system":"sec-edgar","filing":"0001209191-21-052383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121052383/doc4.xml","form_type":"4"}},{"id":2597511,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-18T18:56:04.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":300,"price":157.3133,"value":47193.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.83 to $157.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":386313,"source":{"system":"sec-edgar","filing":"0001209191-21-052383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121052383/doc4.xml","form_type":"4"}},{"id":2614541,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":100,"price":184.99,"value":18499.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":386616,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614540,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":200,"price":183.9,"value":36780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $183.62 to $184.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":386716,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614539,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":400,"price":182.74,"value":73096.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $182.35 to $183.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":386916,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614538,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":1100,"price":181.4724,"value":199619.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $180.98 to $181.93. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":387316,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614537,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":960,"price":180.3281,"value":173114.976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $179.98 to $180.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":388416,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614536,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":1140,"price":179.5341,"value":204668.874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $178.98 to $179.955. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":389376,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2614535,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-04T16:47:39.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":1100,"price":178.4759,"value":196323.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $177.98 to $178.955. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":390516,"source":{"system":"sec-edgar","filing":"0001209191-21-049653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121049653/doc4.xml","form_type":"4"}},{"id":2629101,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T16:08:25.000Z","date":"2021-07-16","kind":"sale","acquired":false,"shares":600,"price":171.4408,"value":102864.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $171.34 to $171.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":391616,"source":{"system":"sec-edgar","filing":"0001209191-21-047362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121047362/doc4.xml","form_type":"4"}},{"id":2629100,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T16:08:25.000Z","date":"2021-07-16","kind":"sale","acquired":false,"shares":2190,"price":170.83,"value":374117.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $170.29 to $171.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":392216,"source":{"system":"sec-edgar","filing":"0001209191-21-047362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121047362/doc4.xml","form_type":"4"}},{"id":2629099,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T16:08:25.000Z","date":"2021-07-16","kind":"sale","acquired":false,"shares":1710,"price":169.745,"value":290263.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $169.24 to $170.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":394406,"source":{"system":"sec-edgar","filing":"0001209191-21-047362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121047362/doc4.xml","form_type":"4"}},{"id":2629098,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T16:08:25.000Z","date":"2021-07-16","kind":"sale","acquired":false,"shares":500,"price":168.565,"value":84282.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $168.075 to $169.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":396116,"source":{"system":"sec-edgar","filing":"0001209191-21-047362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121047362/doc4.xml","form_type":"4"}},{"id":2640806,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":200,"price":196,"value":39200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $195.82 to $196.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":396616,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2640805,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":500,"price":194.2869,"value":97143.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $194.03 to $194.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":396816,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2640804,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":700,"price":193.5064,"value":135454.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $193.02 to $193.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":397316,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2640803,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":700,"price":191.9734,"value":134381.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $191.46 to $192.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":398016,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2640802,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1300,"price":190.8669,"value":248126.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $190.40 to $191.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":398716,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2640801,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T16:30:45.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1600,"price":189.943,"value":303908.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $189.385 to $190.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":400016,"source":{"system":"sec-edgar","filing":"0001209191-21-045480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121045480/doc4.xml","form_type":"4"}},{"id":2660502,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":100,"price":203.42,"value":20342.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":401616,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660501,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":300,"price":202.1763,"value":60652.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $201.825 to $202.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":401716,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660500,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":1000,"price":201.0262,"value":201026.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $200.74 to $201.32. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":402016,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660499,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":1700,"price":200.2309,"value":340392.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $199.725 to $200.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":403016,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660498,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":600,"price":199.3021,"value":119581.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $198.72 to $199.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":404716,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660497,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":500,"price":197.749,"value":98874.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $197.48 to $198.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":405316,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660496,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":400,"price":196.7463,"value":78698.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $196.36 to $197.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":405816,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660495,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":200,"price":195.295,"value":39059.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $194.99 to $195.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":406216,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660494,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":100,"price":191.97,"value":19197.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":406416,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2660493,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-21T17:07:54.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":100,"price":190.97,"value":19097.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":406516,"source":{"system":"sec-edgar","filing":"0001209191-21-042115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121042115/doc4.xml","form_type":"4"}},{"id":2667960,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T17:53:55.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1563,"derivative":{"exercise_price":193.51,"expiration_date":"2031-06-11","underlying":"Class A Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-040695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121040695/doc4.xml","form_type":"4"}},{"id":2667959,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-15T17:53:55.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":406616,"source":{"system":"sec-edgar","filing":"0001209191-21-040695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121040695/doc4.xml","form_type":"4"}},{"id":2682785,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":300,"price":179.7767,"value":53933.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $179.38 to $180.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":405991,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682784,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":300,"price":178.2133,"value":53463.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $177.745 to $178.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":406291,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682783,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":100,"price":176.72,"value":17672.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":406591,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682782,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2400,"price":175.7661,"value":421838.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $175.44 to $176.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":406691,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682781,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1500,"price":174.8,"value":262200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $174.27 to $175.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":409091,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682780,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":600,"price":173.72,"value":104232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $173.16 to $174.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":410591,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682779,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":703,"price":172.5563,"value":121307.0789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $172.09 to $173.025. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":411191,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2682778,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-03T18:51:25.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1597,"price":171.5829,"value":274017.8913,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $171.04 to $172.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":411894,"source":{"system":"sec-edgar","filing":"0001209191-21-037904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121037904/doc4.xml","form_type":"4"}},{"id":2705120,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":600,"price":144.485,"value":86691.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $144.10 to $144.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":413491,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2705119,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":1000,"price":143.4395,"value":143439.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $143.10 to $144.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":414091,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2705118,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":1000,"price":142.4824,"value":142482.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $142.10 to $143.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":415091,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2705117,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":1800,"price":141.3622,"value":254451.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $141.10 to $141.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":416091,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2705116,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":2600,"price":140.3393,"value":364882.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $140.00 to $140.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":417891,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2705115,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T18:18:07.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":500,"price":139.5865,"value":69793.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $139.00 to $139.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":420491,"source":{"system":"sec-edgar","filing":"0001209191-21-034132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121034132/doc4.xml","form_type":"4"}},{"id":2726842,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":100,"price":198.09,"value":19809.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":420991,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726841,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":100,"price":194.9,"value":19490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":421091,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726840,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":300,"price":193.84,"value":58152.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $193.38 to $194.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":421191,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726839,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2200,"price":192.5376,"value":423582.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $192.26 to $193.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":421491,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726838,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2880,"price":191.827,"value":552461.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $191.19 to $192.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":423691,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726837,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":1320,"price":190.5336,"value":251504.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $190.13 to $191.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":426571,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2726836,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-05T17:14:17.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":600,"price":189.2512,"value":113550.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $189.09 to $189.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":427891,"source":{"system":"sec-edgar","filing":"0001209191-21-030399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121030399/doc4.xml","form_type":"4"}},{"id":2744908,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-19T17:02:26.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":300,"price":195.7433,"value":58722.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $195.50 to $196.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":428491,"source":{"system":"sec-edgar","filing":"0001209191-21-027322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121027322/doc4.xml","form_type":"4"}},{"id":2744907,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-19T17:02:26.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":1393,"price":194.8268,"value":271393.7324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $194.40 to $195.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":428791,"source":{"system":"sec-edgar","filing":"0001209191-21-027322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121027322/doc4.xml","form_type":"4"}},{"id":2744906,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":23658,"kind":"person","name":"STUELPNAGEL JOHN R","position":1,"cik":"0001189140","reported_name":"STUELPNAGEL JOHN R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-19T17:02:26.000Z","date":"2021-04-16","kind":"sale","acquired":false,"shares":1600,"price":193.8575,"value":310172.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $193.40 to $194.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":430184,"source":{"system":"sec-edgar","filing":"0001209191-21-027322","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1189140/000120919121027322/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-19T17:02:26.000000Z,2744906"}